Logo image of STRN

STRAN & CO INC (STRN) Stock Fundamental Analysis

NASDAQ:STRN - Nasdaq - US86260J1025 - Common Stock - Currency: USD

1.34  +0.01 (+0.75%)

Fundamental Rating

3

STRN gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 93 industry peers in the Media industry. STRN scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. While showing a medium growth rate, STRN is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

STRN had negative earnings in the past year.
STRN had a negative operating cash flow in the past year.
STRN Yearly Net Income VS EBIT VS OCF VS FCFSTRN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 0 -2M -4M -6M

1.2 Ratios

The profitability ratios for STRN are negative, so there is not much use analyzing them.
Industry RankSector Rank
ROA N/A
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
STRN Yearly ROA, ROE, ROICSTRN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 0 20 40 60

1.3 Margins

STRN does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
STRN Yearly Profit, Operating, Gross MarginsSTRN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 0 10 20 30

6

2. Health

2.1 Basic Checks

STRN does not have a ROIC to compare to the WACC, probably because it is not profitable.
STRN has more shares outstanding than it did 1 year ago.
The debt/assets ratio for STRN has been reduced compared to a year ago.
STRN Yearly Shares OutstandingSTRN Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 5M 10M 15M
STRN Yearly Total Debt VS Total AssetsSTRN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 10M 20M 30M 40M 50M

2.2 Solvency

STRN has an Altman-Z score of 3.42. This indicates that STRN is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 3.42, STRN belongs to the top of the industry, outperforming 91.92% of the companies in the same industry.
A Debt/Equity ratio of 0.06 indicates that STRN is not too dependend on debt financing.
The Debt to Equity ratio of STRN (0.06) is better than 75.76% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF N/A
Altman-Z 3.42
ROIC/WACCN/A
WACC8.58%
STRN Yearly LT Debt VS Equity VS FCFSTRN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 0 10M 20M 30M 40M

2.3 Liquidity

STRN has a Current Ratio of 6.17. This indicates that STRN is financially healthy and has no problem in meeting its short term obligations.
With an excellent Current ratio value of 6.17, STRN belongs to the best of the industry, outperforming 95.96% of the companies in the same industry.
A Quick Ratio of 5.09 indicates that STRN has no problem at all paying its short term obligations.
STRN has a Quick ratio of 5.09. This is amongst the best in the industry. STRN outperforms 94.95% of its industry peers.
Industry RankSector Rank
Current Ratio 6.17
Quick Ratio 5.09
STRN Yearly Current Assets VS Current LiabilitesSTRN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 10M 20M 30M 40M

4

3. Growth

3.1 Past

STRN shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -386.91%.
The Revenue has grown by 46.49% in the past year. This is a very strong growth!
EPS 1Y (TTM)-386.91%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-169.18%
Revenue 1Y (TTM)46.49%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%24.01%

3.2 Future

Based on estimates for the next years, STRN will show a very strong growth in Earnings Per Share. The EPS will grow by 54.55% on average per year.
Based on estimates for the next years, STRN will show a very strong growth in Revenue. The Revenue will grow by 24.75% on average per year.
EPS Next Y-240%
EPS Next 2Y54.92%
EPS Next 3Y54.16%
EPS Next 5Y54.55%
Revenue Next Year44.87%
Revenue Next 2Y32.64%
Revenue Next 3Y29.14%
Revenue Next 5Y24.75%

3.3 Evolution

STRN Yearly Revenue VS EstimatesSTRN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M
STRN Yearly EPS VS EstimatesSTRN Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 0 0.1 0.2

3

4. Valuation

4.1 Price/Earnings Ratio

STRN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Based on the Price/Forward Earnings ratio of 10.95, the valuation of STRN can be described as reasonable.
STRN's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. STRN is cheaper than 67.68% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of STRN to the average of the S&P500 Index (22.70), we can say STRN is valued rather cheaply.
Industry RankSector Rank
PE N/A
Fwd PE 10.95
STRN Price Earnings VS Forward Price EarningsSTRN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
STRN Per share dataSTRN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2

4.3 Compensation for Growth

STRN's earnings are expected to grow with 54.16% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y54.92%
EPS Next 3Y54.16%

0

5. Dividend

5.1 Amount

No dividends for STRN!.
Industry RankSector Rank
Dividend Yield N/A

STRAN & CO INC

NASDAQ:STRN (12/15/2022, 8:25:24 PM)

1.34

+0.01 (+0.75%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryMedia
Earnings (Last)11-14 2022-11-14/bmo
Earnings (Next)N/A N/A
Inst Owners8.24%
Inst Owner Change-98.73%
Ins Owners31.98%
Ins Owner Change0%
Market Cap24.84M
Analysts82.86
Price Target5.61 (318.66%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-81.7%
Min EPS beat(2)-165.36%
Max EPS beat(2)1.96%
EPS beat(4)1
Avg EPS beat(4)-109.59%
Min EPS beat(4)-165.36%
Max EPS beat(4)1.96%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)0.45%
Min Revenue beat(2)-4.93%
Max Revenue beat(2)5.83%
Revenue beat(4)2
Avg Revenue beat(4)1.26%
Min Revenue beat(4)-6.06%
Max Revenue beat(4)10.19%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)N/A
EPS NQ rev (1m)100%
EPS NQ rev (3m)N/A
EPS NY rev (1m)-16.67%
EPS NY rev (3m)N/A
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-2.46%
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 10.95
P/S 0.47
P/FCF N/A
P/OCF N/A
P/B 0.65
P/tB 0.75
EV/EBITDA N/A
EPS(TTM)-0.09
EYN/A
EPS(NY)0.12
Fwd EY9.13%
FCF(TTM)-0.63
FCFYN/A
OCF(TTM)-0.58
OCFYN/A
SpS2.87
BVpS2.08
TBVpS1.78
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA N/A
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover1.11
Health
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 158.17%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 6.17
Quick Ratio 5.09
Altman-Z 3.42
F-Score2
WACC8.58%
ROIC/WACCN/A
Cap/Depr(3y)78.04%
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-386.91%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-169.18%
EPS Next Y-240%
EPS Next 2Y54.92%
EPS Next 3Y54.16%
EPS Next 5Y54.55%
Revenue 1Y (TTM)46.49%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%24.01%
Revenue Next Year44.87%
Revenue Next 2Y32.64%
Revenue Next 3Y29.14%
Revenue Next 5Y24.75%
EBIT growth 1Y-221.37%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year1649.56%
EBIT Next 3Y279.72%
EBIT Next 5Y214.27%
FCF growth 1Y-187.29%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-193.22%
OCF growth 3YN/A
OCF growth 5YN/A